共 69 条
[1]
Skelly J. P.(1990)Report of the workshop on in-vitro and in-vivo testing and correlation for oral controlled/modified-release dosage forms J. Pharm. Sci. 79 849-854
[2]
Amidon G. L.(1985)Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients Br. J. Clin. Pharmacol. 20 387-391
[3]
Barr W. H.(1993)Steady-state bioavailability and day-to-day variability of a multiple unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing Pharm. Res. 10 28-34
[4]
Benet L. Z.(1988)Design of a new multiple-unit controlled-release formulation of metoprolol-CR Eur. J. Clin. Pharmacol. 33 S3-S7
[5]
Carter J. E.(1995)A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 413-420
[6]
Robinson J. R.(1997)Evaluation of Pharmaceutical Dev. Tech. 29 11-24
[7]
Shah V. P.(1989) Release Rate and Euro. J. Clin. Pharmacol. 1989 315-318
[8]
Yacobi A.(1996) Absorption characteristics of Four Metoprolol Tartrate Immediate Release Tablet Formulations Pharm. Tech. 6 64-74
[9]
Silas J. H.(1981)Determination of dextromethorphan metabolizer phenotype in healthy volunteers Clin. Pharmacokin. 6 429-453
[10]
Freestone S.(1981)Mathematical comparison of curves with an emphasis on dissolution profiles J. Pharmacokinet. Biopharm. 9 503-512